Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alumites study of subcutaneous mite immunotherapy in allergic rhinitis
2009-018155-16Phase 4Active
- Sponsor
- Stallergenes Greer
- Start
- Apr 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Alustal in allergic rhinitis (AR) (2 arms), sponsored by Stallergenes Greer. Primary endpoint: Change in nasal obstruction after nasal allergen provocation. Started Apr 2010; status: active.
02
Drugs
Alustal
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2009-018155-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018155-16.